Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 103

1.

11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy.

Giovacchini G, Picchio M, Garcia-Parra R, Briganti A, Abdollah F, Gianolli L, Schindler C, Montorsi F, Messa C, Fazio F.

J Nucl Med. 2014 Feb;55(2):233-41. doi: 10.2967/jnumed.113.123380. Epub 2014 Jan 9.

2.

Characterization of biological features of a rat F98 GBM model: a PET-MRI study with [18F]FAZA and [18F]FDG.

Belloli S, Brioschi A, Politi LS, Ronchetti F, Calderoni S, Raccagni I, Pagani A, Monterisi C, Zenga F, Zara G, Fazio F, Mauro A, Moresco RM.

Nucl Med Biol. 2013 Aug;40(6):831-40. doi: 10.1016/j.nucmedbio.2013.05.004.

3.

Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.

Valtorta S, Belloli S, Sanvito F, Masiello V, Di Grigoli G, Monterisi C, Fazio F, Picchio M, Moresco RM.

J Nucl Med. 2013 Jul;54(7):1106-12. doi: 10.2967/jnumed.112.111120. Epub 2013 May 22.

4.

Clinical and immunologic responses in melanoma patients vaccinated with MAGE-A3-genetically modified lymphocytes.

Russo V, Pilla L, Lunghi F, Crocchiolo R, Greco R, Ciceri F, Maggioni D, Fontana R, Mukenge S, Rivoltini L, Rigamonti G, Mercuri SR, Nicoletti R, Maschio AD, Gianolli L, Fazio F, Marchianò A, Florio AD, Maio M, Salomoni M, Gallo-Stampino C, Fiacco MD, Lambiase A, Coulie PG, Patuzzo R, Parmiani G, Traversari C, Bordignon C, Santinami M, Bregni M.

Int J Cancer. 2013 Jun 1;132(11):2557-66. doi: 10.1002/ijc.27939. Epub 2012 Dec 13.

5.

The p53-p66Shc apoptotic pathway is dispensable for tumor suppression whereas the p66Shc-generated oxidative stress initiates tumorigenesis.

Beltrami E, Valtorta S, Moresco R, Marcu R, Belloli S, Fassina A, Fazio F, Pelicci P, Giorgio M.

Curr Pharm Des. 2013;19(15):2708-14.

PMID:
23092318
6.

Time course of metabolic activity and cellular infiltration in a murine model of acid-induced lung injury.

Zambelli V, Di Grigoli G, Scanziani M, Valtorta S, Amigoni M, Belloli S, Messa C, Pesenti A, Fazio F, Bellani G, Moresco RM.

Intensive Care Med. 2012 Apr;38(4):694-701. doi: 10.1007/s00134-011-2456-1. Epub 2012 Jan 26.

PMID:
22278592
7.

Evaluation of the role of tumor-associated macrophages in an experimental model of peritoneal carcinomatosis using (18)F-FDG PET.

Cottone L, Valtorta S, Capobianco A, Belloli S, Rovere-Querini P, Fazio F, Manfredi AA, Moresco RM.

J Nucl Med. 2011 Nov;52(11):1770-7. doi: 10.2967/jnumed.111.089177.

8.

Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety.

Giuliani G, Cappelli A, Matarrese M, Masiello V, Turolla EA, Monterisi C, Fazio F, Anzini M, Pericot Mohr G, Riitano D, Finetti F, Morbidelli L, Ziche M, Giorgi G, Vomero S.

Bioorg Med Chem. 2011 Apr 1;19(7):2242-51. doi: 10.1016/j.bmc.2011.02.031. Epub 2011 Feb 24.

PMID:
21421318
9.

Hepatocellular carcinoma treated with transarterial chemoembolization: dynamic perfusion-CT in the assessment of residual tumor.

Ippolito D, Bonaffini PA, Ratti L, Antolini L, Corso R, Fazio F, Sironi S.

World J Gastroenterol. 2010 Dec 21;16(47):5993-6000.

10.

4D-PET data sorting into different number of phases: a NEMA IQ phantom study.

Mancosu P, Sghedoni R, Bettinardi V, Fioroni F, Aquilina MA, Grassi E, Fazio F, Borasi G, Gilardi MC.

J Appl Clin Med Phys. 2009 Oct 28;10(4):220-31.

11.

Fluorodeoxyglucose uptake measured by positron emission tomography and standardized uptake value predicts long-term survival of CT screening detected lung cancer in heavy smokers.

Pastorino U, Landoni C, Marchianò A, Calabrò E, Sozzi G, Miceli R, Picchio M, Mariani L, Messa C, Fazio F.

J Thorac Oncol. 2009 Nov;4(11):1352-6. doi: 10.1097/JTO.0b013e3181bbf1dc.

12.

A modified damped Richardson-Lucy algorithm to reduce isotropic background effects in spherical deconvolution.

Dell'acqua F, Scifo P, Rizzo G, Catani M, Simmons A, Scotti G, Fazio F.

Neuroimage. 2010 Jan 15;49(2):1446-58. doi: 10.1016/j.neuroimage.2009.09.033. Epub 2009 Sep 23.

PMID:
19781650
13.

Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy.

Giovacchini G, Picchio M, Coradeschi E, Bettinardi V, Gianolli L, Scattoni V, Cozzarini C, Di Muzio N, Rigatti P, Fazio F, Messa C.

Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):301-9. doi: 10.1007/s00259-009-1253-3. Epub 2009 Sep 15.

PMID:
19756592
14.

Automated production of copper radioisotopes and preparation of high specific activity [(64)Cu]Cu-ATSM for PET studies.

Matarrese M, Bedeschi P, Scardaoni R, Sudati F, Savi A, Pepe A, Masiello V, Todde S, Gianolli L, Messa C, Fazio F.

Appl Radiat Isot. 2010 Jan;68(1):5-13. doi: 10.1016/j.apradiso.2009.08.010. Epub 2009 Aug 25.

PMID:
19736021
15.

Changes in glucose metabolism during and after radiotherapy in non-small cell lung cancer.

Giovacchini G, Picchio M, Schipani S, Landoni C, Gianolli L, Bettinardi V, Di Muzio N, Gilardi MC, Fazio F, Messa C.

Tumori. 2009 Mar-Apr;95(2):177-84.

PMID:
19579863
16.

Lungs of patients with acute respiratory distress syndrome show diffuse inflammation in normally aerated regions: a [18F]-fluoro-2-deoxy-D-glucose PET/CT study.

Bellani G, Messa C, Guerra L, Spagnolli E, Foti G, Patroniti N, Fumagalli R, Musch G, Fazio F, Pesenti A.

Crit Care Med. 2009 Jul;37(7):2216-22. doi: 10.1097/CCM.0b013e3181aab31f.

PMID:
19487931
17.

Dose-volume relationships for acute bowel toxicity in patients treated with pelvic nodal irradiation for prostate cancer.

Fiorino C, Alongi F, Perna L, Broggi S, Cattaneo GM, Cozzarini C, Di Muzio N, Fazio F, Calandrino R.

Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):29-35. doi: 10.1016/j.ijrobp.2008.10.086. Epub 2009 May 19.

PMID:
19467803
18.

Monitoring disease evolution and treatment response in lysosomal disorders by the peripheral benzodiazepine receptor ligand PK11195.

Visigalli I, Moresco RM, Belloli S, Politi LS, Gritti A, Ungaro D, Matarrese M, Turolla E, Falini A, Scotti G, Naldini L, Fazio F, Biffi A.

Neurobiol Dis. 2009 Apr;34(1):51-62.

PMID:
19320046
19.

Characterization of preclinical models of prostate cancer using PET-based molecular imaging.

Belloli S, Jachetti E, Moresco RM, Picchio M, Lecchi M, Valtorta S, Freschi M, Hess Michelini R, Bellone M, Fazio F.

Eur J Nucl Med Mol Imaging. 2009 Aug;36(8):1245-55. doi: 10.1007/s00259-009-1091-3. Epub 2009 Mar 11.

PMID:
19280188
20.

Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.

Da Pozzo LF, Cozzarini C, Briganti A, Suardi N, Salonia A, Bertini R, Gallina A, Bianchi M, Fantini GV, Bolognesi A, Fazio F, Montorsi F, Rigatti P.

Eur Urol. 2009 May;55(5):1003-11. doi: 10.1016/j.eururo.2009.01.046. Epub 2009 Feb 4.

PMID:
19211184

Supplemental Content

Loading ...
Support Center